Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04364503 · ClinicalTrials.gov registry record
Compliant Analysis of Patient Samples and Data
A clinical trial of Cancer and Pregnancy Related, sponsored by Sequenom.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT04364503 is a study of Cancer and Pregnancy Related that is actively recruiting participants, run by Sequenom. The registered enrollment target is 2,000 participants, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04364503, a study of Cancer and Pregnancy Related, is actively recruiting participants, sponsored by Sequenom.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
Conditions Studied
Interventions
- DEVICE Multiple interventions depending on diagnostic test being run.
Study Locations (1)
California
- Sequenom, Inc - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2018-03-17 |
| Est. Completion | 2030-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04364503
The ClinicalTrials.gov registry entry for NCT04364503 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (43% lower). The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Multiple interventions depending on diagnostic test being run. is the first listed.
NCT04364503 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04364503 about?
NCT04364503 is a clinical study titled "Compliant Analysis of Patient Samples and Data". Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
What is the current status of trial NCT04364503?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2018-03-17. Estimated completion is 2030-08-15.
What conditions does trial NCT04364503 study?
This clinical trial studies the following conditions: Cancer, Pregnancy Related, Infectious Disease.
What interventions are being tested in trial NCT04364503?
The interventions under investigation include: Multiple interventions depending on diagnostic test being run. (DEVICE).
Who is sponsoring clinical trial NCT04364503?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04364503 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.